Posted by zero on April 15, 2002, at 13:31:16
In reply to New Antidepressants in Development?, posted by DP on April 14, 2002, at 22:11:50
(hope this long list is informative - zero)
CenterWatch's comprehensive Directory of Drugs in Clinical Trials:
Company Name Trade Name Generic Name Condition(s), Phase(s)
GlaxoSmithKline Paxil, Seroxat paroxetine Depression, III
Yamanouchi Pharmaceutical N/A YM-992 Depression, II
Wyeth Research Effexor XR venlafaxine HCl Depression, FDA approved
Janssen Pharmaceutica N/A YKP-10A Depression, IIa completed
Merck N/A substance P antagonist candidates Depression, IIa
Merck N/A MK-869 Depression, III
Cephalon Provigil modafinil Depression, II
Boehringer Ingelheim N/A flibanserin Depression, II
Merck KgaA N/A anti-depressant Depression, II
Sanofi-Synthelabo Pharmaceuticals N/A SR 58611 Depression, II b
Eli Lilly N/A duloxetine HCl, LY-248686 Depression, NDA submitted
Innapharma N/A INN-00835 Depression, II completed
NeuroSearch A/S N/A NS-2389 Depression, II
Eli Lilly Zyprexa olanzapine Depression, III
Neurocrine Biosciences N/A NBI-34041 Depression, I
NPS Pharmaceuticals N/A NPS 1506 Depression, Ib completed
Kyowa Hakko N/A KW-6002 Depression, II
Forest Laboratories N/A escitalopram Depression, NDA submitted
AstraZeneca N/A robalzotan, NAD 299 Depression, II
Solvay Pharmaceuticals N/A SLV 308 Depression, II
Takeda Chemical Industries N/A TAK-637 Depression, II
Organon Ariza 5HT-1A partial agonist Depression, III
Annovis N/A amino-cyclopropane carboxylic acid Depression, I
GlaxoSmithKline N/A GW 597599 Depression, I
GlaxoSmithKline N/A SB 243213 Depression, Discontinued
GlaxoSmithKline N/A SB 659746A, EMD 68843 Depression, II
GlaxoSmithKline N/A GW 650250 Depression, II
Janssen Pharmaceutica N/A R 107474 Depression, Discontinued
Janssen Pharmaceutica N/A CRF receptor antagonist, NBI-37582 Depression, I
Pfizer N/A NGD 98-1 Depression, II
Eli Lilly Prozac Weekly fluoxetine HCI Depression, FDA approved
Eli Lilly Prozac fluoxetine HCl Depression, FDA approved
Eli Lilly N/A Olanzapine-fluoxetine combination Depression, III
Fabre-Kramer Pharmaceuticals N/A gepirone Depression, III completed
Pfizer N/A JO-1784, CI-1019 Depression, Discontinued
Dainippon Pharmaceutical N/A moclobemide Depression, II
Pfizer N/A CP-122,721 Depression, II
Hoffmann-La Roche N/A NK-1 Depression, I
Otsuka America Pharmaceutical N/A OPC-14523 Depression, II
Organon N/A ORG-12962 Depression, II
Cortex Pharmaceuticals N/A ORG-24448, CX-619 Depression, I
Organon N/A ORG-34167 Depression, I
Organon N/A ORG-34517 Depression, II
Pharmacia Vestra reboxetine Depression, FDA denied
Mitsubishi Chemical Corporation N/A MCI-225 Depression, II
Somerset Pharmaceuticals Emsam selegiline Depression, NDA denied
GlaxoSmithKline N/A SB723620 Depression, I
Sepracor N/A (R)-sibutramine metabolite Depression, II
poster:zero
thread:103083
URL: http://www.dr-bob.org/babble/20020408/msgs/103143.html